Three updated Cochrane Reviews evaluate treatment options in chronic kidney disease
This article has no abstract so we have provided the first paragraph of the full text.
A trio of new systematic analyses of data on calcimimetics for secondary hyperparathyroidism, management of progression of diabetic kidney disease, and different dialysis modalities, highlight the need for more large, high-quality trials in these areas.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
